Sarah Nikiforow

11.3k citations

152 papers · 3.4k indexed · 1 hit paper · h-index 31

Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 58
Immunology top 2%
- Immune Cell Function and Interaction 45
- T-cell and B-cell Immunology 22
Oncology top 1%
- CAR-T cell therapy research 46
- Viral-associated cancers and disorders 17
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 13
Transplantation top 5%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 15
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 14

Co-authors: Joseph H. Antin Corey Cutler Robert J. Soiffer George Miller Jerome Ritz Vincent T. Ho John Koreth Edwin P. Alyea
Cited by: Hematology Immunology Oncology
Journals: New England Journal of Medicine (1 paper)The Journal of Experimental Medicine (2 papers)Journal of Clinical Oncology (5 papers)
Partner nations: United States France Canada

In The Last Decade

Sarah Nikiforow

142 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Sarah Nikiforow

Since Specialization

Citations

This map shows the geographic impact of Sarah Nikiforow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Nikiforow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Nikiforow more than expected).

Fields of papers citing papers by Sarah Nikiforow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Nikiforow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Nikiforow. The network helps show where Sarah Nikiforow may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sarah Nikiforow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah Nikiforow Line = papers co-authored together Sarah Nikiforow links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Updated Clinical Results: A Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein–Barr Virus–Driven Posttransplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab Plus Chemotherapy Transplantation and Cellular Therapy ·Armin Ghobadi,Robert A. Baiocchi,Prof. Amer Beitinjaneh,Sridhar Chaganti,Sylvain Choquet,Daan Derickx,Rajani Dinavahi,Xinyuan Duan,Laurence Gamelin,Kris M. Mahadeo,Aditi Mehta,Sarah Nikiforow,Ran Reshef,Sandrine Roye,Jean-Claude Vedovato,Susan E. Prockop	2025	0
2	Awakening from REMS: ASTCT 80/20 Ongoing Recommendations for Safe Use of Chimeric Antigen Receptor T Cells Transplantation and Cellular Therapy ·Frederick L. Locke,Zahra Mahmoudjafari,Partow Kebriaei,Rebecca Gardner,Matthew J. Frigault,Noelle V. Frey,Krishna V. Komanduri,Miguel‐Angel Perales,Sarah Nikiforow	2025	3
3	Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry Blood Advances ·Samuel John,Kevin J. Curran,Erin Hall,Amy K. Keating,Susanne H.C. Baumeister,Sarah Nikiforow,Timothy Driscoll,Amy Moskop,Kevin O. McNerney,Christine L. Phillips,Michael A. Pulsipher,Emily M. Hsieh,Rayne H. Rouce,Marcelo C. Pasquini,Ranjan Tiwari,Jennifer Willert,Roberto Ramos,Joerg Krueger,Erin Guest,Stephan A. Grupp	2025	0
4	Comparison of Older Related versus Younger Unrelated Donors for Older Recipients of Allogeneic Hematopoietic Cell Transplantation with Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Large Single-Center Analysis Transplantation and Cellular Therapy ·Haesook T. Kim,Vincent T. Ho,Sarah Nikiforow,Corey Cutler,John Koreth,Roman M. Shapiro,Mahasweta Gooptu,Rizwan Romee,Catherine J. Wu,Joseph H. Antin,Jerome Ritz,Robert J. Soiffer	2024	3
5	Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19? UNC Libraries ·Sarah Nikiforow,Michael K. Mansour,Zhen‐Huan Hu,Mary M. Horowitz,Peiman Hematti,Miguel‐Angel Perales,Marcie Riches,Cameron J. Turtle,Matthew J. Frigault,Marcelo C. Pasquini,Mei-Jie Zhang	2024	0
6	Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol Blood Advances ·Sarah Nikiforow,Jennifer Whangbo,Ran Reshef,Donald E. Tsai,Nancy Bunin,Rolla Abu‐Arja,Kris M. Mahadeo,Wen‐Kai Weng,Koen van Besien,David M. Loeb,Sunita D. Nasta,Eneida R. Nemecek,Weizhi Zhao,Yan Sun,Faith Galderisi,Justin T. Wahlstrom,Aditi Mehta,Laurence Gamelin,Rajani Dinavahi,Susan E. Prockop	2024	8
7	Cytokine release syndrome in haploidentical stem cell transplant may impact T-cell recovery and relapse Blood Advances ·Roman M. Shapiro,Haesook T. Kim,Michela Ansuinelli,Indira Guleria,Corey Cutler,John Koreth,Mahasweta Gooptu,Joseph H. Antin,Amar H. Kelkar,Jerome Ritz,Catherine J. Wu,Robert J. Soiffer,Vincent T. Ho,Sarah Nikiforow,Rizwan Romee	2023	2
8	Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy Transplantation and Cellular Therapy ·Olalekan O. Oluwole,Bhagirathbhai Dholaria,Tristan Knight,Tania Jain,Frederick L. Locke,Linda Ramsdell,Sarah Nikiforow,Hamza Hashmi,Kathy Mooney,Shakthi Bhaskar,Katrina Morris,Katie S. Gatwood,Brittney Baer,Larry D. Anderson,Mehdi Hamadani	2023	17
9	Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD Blood Advances ·Katie Maurer,Vincent T. Ho,Eno Inyang,Corey Cutler,John Koreth,Roman M. Shapiro,Mahasweta Gooptu,Rizwan Romee,Sarah Nikiforow,Joseph H. Antin,Catherine J. Wu,Jerome Ritz,Robert J. Soiffer,Haesook T. Kim	2023	14
10	Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells Blood Advances ·Katie Maurer,Haesook T. Kim,Heather Garrity,Deborah Liney,Corey Cutler,Joseph H. Antin,John Koreth,Jerome Ritz,Roman M. Shapiro,Rizwan Romee,Vincent T. Ho,Mahasweta Gooptu,Robert J. Soiffer,Catherine J. Wu,Sarah Nikiforow	2023	7
11	Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation Transplantation and Cellular Therapy ·Juliana Vergara-Cadavid,P. Connor Johnson,Haesook T. Kim,Alisha Yi,Meghan E. Sise,David E. Leaf,Paul E. Hanna,Vincent T. Ho,Corey Cutler,Joseph H. Antin,Mahasweta Gooptu,Amar H. Kelkar,Sophia L. Wells,Sarah Nikiforow,John Koreth,Rizwan Romee,Robert J. Soiffer,Roman M. Shapiro,Shruti Gupta	2023	3
12	Low Dose IL-2 Therapy in Patients with Chronic Gvhd Induces PD-1+treg That Are Highly Activated, Immune Suppressive, and Proapoptotic Transplantation and Cellular Therapy ·Shuntaro Ikegawa,Takeru Asano,Haesook T. Kim,Gordon J. Freeman,Xia Bu,Roger Belizaire,Jennifer Whangbo,Rizwan Romee,Mahasweta Gooptu,Roman M. Shapiro,Sarah Nikiforow,Vincent T. Ho,Corey Cutler,Joseph H. Antin,Robert J. Soiffer,John Koreth,Jerome Ritz	2022	1
13	Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome Transplantation and Cellular Therapy ·Jessica S Little,Roman M. Shapiro,Muneerah M Aleissa,Austin Kim,Jun Bai Park Chang,David W. Kubiak,Guohai Zhou,Joseph H. Antin,John Koreth,Sarah Nikiforow,Corey Cutler,Rizwan Romee,Nicolas C. Issa,Vincent T. Ho,Mahasweta Gooptu,Robert J. Soiffer,Lindsey R. Baden	2022	8
14	COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience Blood Advances ·Katie Maurer,Anna Saucier,Haesook T. Kim,Utkarsh Acharya,Clifton C. Mo,Julie Porter,Cindy Albert,Corey Cutler,Joseph H. Antin,John Koreth,Mahasweta Gooptu,Rizwan Romee,Catherine J. Wu,Robert J. Soiffer,Sarah Nikiforow,Caron A. Jacobson,Vincent T. Ho	2021	24
15	Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution Blood Advances ·Katie Maurer,Haesook T. Kim,Thomas M. Kuczmarski,Heather Garrity,Augustine Weber,Carol Reynolds,Deborah Liney,Corey Cutler,Joseph H. Antin,John Koreth,Jerome Ritz,Roman M. Shapiro,Rizwan Romee,Catherine J. Wu,Robert J. Soiffer,Sarah Nikiforow,Vincent T. Ho,Mahasweta Gooptu	2021	20
16	An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis Blood ·Adi Zoref‐Lorenz,Jun Murakami,Liron Hofstetter,Swaminathan P. Iyer,Ahmad S. Alotaibi,Shehab Mohamed,Peter G. Miller,Elad Guber,Shiri Weinstein,Joanne Yacobovich,Sarah Nikiforow,Benjamin L. Ebert,Adam Lane,Oren Pasvolsky,Pia Raanani,Arnon Nagler,Nancy Berliner,Naval Daver,Martin Ellis,Michael B. Jordan	2021	68
17	Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US) Blood ·Marcelo C. Pasquini,Frederick L. Locke,Alex F. Herrera,Tanya Siddiqi,Armin Ghobadi,Krishna V. Komanduri,Zhen‐Huan Hu,Hua Dong,Peiman Hematti,Sarah Nikiforow,Patricia Steinert,Anna Purdum,Mary M. Horowitz,Michelle Hooper,Jun Kawashima,Caron A. Jacobson	2019	72
18	Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Clinton Lewis,Haesook T. Kim,Lindsey E. Roeker,Corey Cutler,John Koreth,Sarah Nikiforow,Philippe Armand,Mahasweta Gootpu,Rizwan Romee,Brett Glotzbecker,Prashant Nageshwar,Joseph H. Antin,Edwin P. Alyea,Paul G. Richardson,Robert J. Soiffer,Vincent T. Ho	2019	16
19	Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder Biology of Blood and Marrow Transplantation ·Susan E. Prockop,Ai Li,Robert A. Baiocchi,Nancy Bunin,Kris M. Mahadeo,Eneida R. Nemecek,Sarah Nikiforow,Ran Reshef,Donald E. Tsai,Willis H. Navarro,Richard J. O’Reilly	2018	6
20	Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients Blood Advances ·Erica B. Esrick,John Manis,Heather Daley,Cristina Baricordi,Hélène Trebeden‐Negre,Francis J. Pierciey,Myriam Armant,Sarah Nikiforow,Matthew M. Heeney,Wendy B. London,Luca Biasco,Mohammed Asmal,David A. Williams,Alessandra Biffi	2018	59

About Sarah Nikiforow

Sarah Nikiforow is a scholar working on Hematology, Immunology and Oncology, having authored 152 papers that have together received 3.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (58 papers), CAR-T cell therapy research (46 papers), Immune Cell Function and Interaction (45 papers), T-cell and B-cell Immunology (22 papers), Viral-associated cancers and disorders (17 papers), Lymphoma Diagnosis and Treatment (15 papers), Acute Lymphoblastic Leukemia research (14 papers) and Chronic Lymphocytic Leukemia Research (13 papers). The work is most often cited by research in Hematology (1.2k citations), Immunology (1.4k citations) and Oncology (1.8k citations). Sarah Nikiforow has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Joseph H. Antin, Corey Cutler, Robert J. Soiffer, George Miller, Jerome Ritz, Vincent T. Ho, John Koreth, Edwin P. Alyea, Haesook T. Kim and Philippe Armand. Their work appears in journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact